Sepsis Research Today is a free monthly online journal that collates and summarizes the latest research about Sepsis, including details on septicemia, diagnosis, symptoms, treatment.

Volume 2 (2005), Issue 7 (July)

1. Multicenter prospective study of procalcitonin as an indicator of sepsis.
   J Infect Chemother, 11(3): 152-9. [Abstract] [Full-text]
2. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.
   J Infect Dis, 192(3): 510-9. [Abstract] [Full-text]
3. Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
   J Virol, 79(14): 9026-37. [Abstract] [Full-text]
4. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
   Clin Immunol, 116(2): 158-65. [Abstract] [Full-text]
5. Does disseminated intravascular coagulation lead to multiple organ failure?
   Crit Care Clin, 21(3): 469-77. [Abstract] [Full-text]
6. Disseminated intravascular coagulation: What's new?
   Crit Care Clin, 21(3): 449-67. [Abstract] [Full-text]
7. Tissue factor pathway inhibitor and antithrombin trial results.
   Crit Care Clin, 21(3): 433-48. [Abstract] [Full-text]
8. Sepsis and coagulation.
   Crit Care Clin, 21(3): 417-31. [Abstract] [Full-text]
9. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001.
   Eur J Clin Microbiol Infect Dis, 24(6): 399-404. [Abstract] [Full-text]
10. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia.
    Eur J Clin Microbiol Infect Dis, 24(6): 384-7. [Abstract] [Full-text]
11. Potential substitution of cord blood for infant blood in the neonatal sepsis evaluation.
    Biol Neonate, 88(1): 12-8. [Abstract] [Full-text]
12. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Clin Exp Immunol, 141(2): 270-8. [Abstract] [Full-text]
13. Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome.
    J Clin Microbiol, 43(7): 3570-3. [Abstract] [Full-text]
14. Bacteremia caused by an undescribed species of Janibacter.
    J Clin Microbiol, 43(7): 3564-6. [Abstract] [Full-text]
15. Discordant rise in galactomannan antigenemia in a patient with resolving Aspergillosis, renal failure, and ongoing hemodialysis.
    J Clin Microbiol, 43(7): 3560-3. [Abstract] [Full-text]
16. Bacteremia caused by Janibacter melonis.
    J Clin Microbiol, 43(7): 3537-9. [Abstract] [Full-text]
17. Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria.
    J Clin Microbiol, 43(7): 3447-9. [Abstract] [Full-text]
18. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 43(7): 3435-7. [Abstract] [Full-text]
19. Septic pulmonary embolism: presenting features and clinical course of 14 patients.
    Chest, 128(1): 162-6. [Abstract] [Full-text]
20. Rapid and quantitative detection of blood Serratia marcescens by a real-time PCR assay: its clinical application and evaluation in a mouse infection model.
    FEMS Microbiol Lett, 248(2): 163-70. [Abstract] [Full-text]
21. Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia.
    Am J Physiol Lung Cell Mol Physiol, 289(2): L244-51. [Abstract] [Full-text]
22. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities.
    Ann Trop Med Parasitol, 99(5): 441-8. [Abstract] [Full-text]
23. Thermal injury and sepsis modulates beta-adrenergic receptors and cAMP responses in monocyte-committed bone marrow cells.
    J Neuroimmunol, 165(1): 129-38. [Abstract] [Full-text]
24. Malaria and asymptomatic parasitaemia in Gabonese infants under the age of 3 months.
    Acta Trop, 95(2): 81-5. [Abstract] [Full-text]
25. A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis.
    Am J Physiol Renal Physiol, 289(2): F369-76. [Abstract] [Full-text]
26. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Arch Intern Med, 165(13): 1533-40. [Abstract] [Full-text]
27. Device-related infections in children.
    Pediatr Clin North Am, 52(4): 1189-208, x. [Abstract] [Full-text]
28. Non-Typhi Salmonella gastroenteritis in children presenting to the emergency department: characteristics of patients with associated bacteraemia.
    Clin Microbiol Infect, 11(8): 651-5. [Abstract] [Full-text]
29. Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality.
    Clin Microbiol Infect, 11(8): 618-24. [Abstract] [Full-text]
30. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Scand J Infect Dis, 37(6): 488-92. [Abstract] [Full-text]
31. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
    Scand J Infect Dis, 37(6): 455-64. [Abstract] [Full-text]
32. Incidence of pneumococcal endocarditis: a regional health register-based study in Denmark 1981-1996.
    Scand J Infect Dis, 37(6): 417-21. [Abstract] [Full-text]
33. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
    J Virol, 79(15): 9625-34. [Abstract] [Full-text]
34. Central line-related bacteremia due to Roseomonas mucosa in a patient with diffuse large B-cell non-Hodgkin's lymphoma.
    Leuk Lymphoma, 46(4): 611-4. [Abstract] [Full-text]
35. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes.
    J Intern Med, 258(2): 172-80. [Abstract] [Full-text]
36. Comparison of neutrophil CD64 expression, manual myeloid immaturity counts, and automated hematology analyzer flags as indicators of infection or sepsis.
    Lab Hematol, 11(2): 137-47. [Abstract] [Full-text]
37. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.
    J Infect Dis, 192(4): 607-17. [Abstract] [Full-text]
38. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.
    Arch Surg, 140(7): 661-8; discussion 669. [Abstract] [Full-text]
39. Systemic low-grade inflammation and risk of coronary heart disease: results from the MONICA/KORA Augsburg cohort studies.
    Gesundheitswesen, 67: S62-7. [Abstract] [Full-text]
40. Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis. Highlights from the 25th International Symposium on Intensive Care and Emergency Medicine. March 21-25, 2005, Brussels, Belgium.
    Drugs Today (Barc), 41(4): 253-6. [Abstract] [Full-text]
41. Neuromuscular manifestations of critical illness.
    Muscle Nerve, 32(2): 140-63. [Abstract] [Full-text]
42. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies.
    Anesth Analg, 101(2): 488-98. [Abstract] [Full-text]
43. Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
    J Antimicrob Chemother, 56(1): 186-9. [Abstract] [Full-text]
44. Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya.
    J Antimicrob Chemother, 56(1): 232-5. [Abstract] [Full-text]
45. Divergence of protection induced by bacterial products and sepsis-induced immune suppression.
    Infect Immun, 73(8): 4905-12. [Abstract] [Full-text]
46. Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.
    J Med Virol, 77(1): 77-82. [Abstract] [Full-text]
47. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    J Med Virol, 77(1): 23-8. [Abstract] [Full-text]
48. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.
    Arch Intern Med, 165(14): 1643-50. [Abstract] [Full-text]
49. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
    Antimicrob Agents Chemother, 49(8): 3208-16. [Abstract] [Full-text]
50. Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia.
    Antimicrob Agents Chemother, 49(8): 3171-7. [Abstract] [Full-text]
51. Helicobacter cinaedi-associated bacteraemia and erysipelas in an immunocompetent host: a diagnostic challenge.
    Scand J Infect Dis, 37(5): 382-5. [Abstract] [Full-text]
52. Equine neonatal sepsis.
    Vet Clin North Am Equine Pract, 21(2): 273-93, v. [Abstract] [Full-text]
53. Leukocyte apoptosis and its significance in sepsis and shock.
    J Leukoc Biol, 78(2): 325-37. [Abstract] [Full-text]

© 2004-2008 Sepsis Research Today. All Rights Reserved.